You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite instable colorectal

Showing 1 - 25 of 5,571
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma Trial in Shanghai (Vitamin E, Fruquintinib, Tislelizumab)

Not yet recruiting
  • Colorectal Cancer
  • Microsatellite Stable Colorectal Carcinoma
  • Vitamin E
  • +2 more
  • Shanghai, Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Mar 5, 2023

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Colorectal Cancer Trial (KN046, regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Aug 2, 2023

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

Active, not recruiting
  • Colorectal Cancer
  • IBI310 (anti-CTLA-4 antibody)
  • Sintilimab(anti-PD-1 antibody)
  • Beijing, China
    Beijing cancer hospital
Sep 15, 2022

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting
  • Advanced Colorectal Adenocarcinoma
  • +5 more
  • Balstilimab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Colorectal Cancer Trial in Harbin (AK119, AK112, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Harbin, China
    Cancer Hospital Affiliated to Harbin Medical University
May 5, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Tucson, Arizona
  • +2 more
Jul 28, 2022

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Colorectal Cancers With Microsatellite Instability

Active, not recruiting
  • Colorectal Cancer
  • Microsatellite Instability
    • Poitiers, Vienne, France
    • +13 more
    Aug 19, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Terminated
    • Metastatic Colon Adenocarcinoma
    • +27 more
    • San Francisco, California
    • +1 more
    Jan 5, 2023

    Microsatellite Instability in Colorectal Cancers

    Completed
    • Colorectal Cancer
    • +4 more
    • Microsatellite instability analysis
    • Istanbul, Turkey
      Sultan 2. Abdulhamid Training and Research Hospital
    Dec 5, 2021

    MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

    Recruiting
    • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
    • Kashiwa, Chiba, Japan
      Novartis Investigative Site
    May 2, 2023

    Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

    Recruiting
    • Microsatellite Stable Metastatic Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 19, 2023

    MSI-H Colorectal Cancer Trial (colorectal resection)

    Completed
    • MSI-H Colorectal Cancer
    • colorectal resection
    • (no location specified)
    May 22, 2023

    Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

    Recruiting
    • Metastatic Microsatellite-stable Colorectal Cancer
    • Experimental drug
    • Control Rx
    • Hefei, Anhui, China
    • +11 more
    Mar 13, 2023

    Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

    Recruiting
    • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
    • Colorectal Adenocarcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • MSS
    • Heidelberg, Germany
      National Center for Tumor Diseases, University Hospital Heidelbe
    May 17, 2022

    Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Neoadjuvant therapy with PD-L1 inhibitor
    • Guangzhou, Guangdong, China
      the Third Affiliated Hospital of Sun Yat-Sen University
    May 10, 2022

    New Patient Stratification Tools in MSS RAS mt mCRC

    Completed
    • Advanced Colorectal Cancer
      • Heidelberg, Germany
      • +9 more
      Nov 25, 2022

      Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial (Cadonilimab)

      Not yet recruiting
      • Colorectal Cancer Stage IV
      • +2 more
      • (no location specified)
      Jun 19, 2022

      Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

      Not yet recruiting
      • Colorectal Cancer
      • all trans Retinoic Acid
      • +2 more
      • (no location specified)
      Aug 11, 2023